coltuximab ravtansine (TAB-H15)

Anti-Human CD19 Therapeutic Antibody TAB-H15 1mg Please Inquiry


  • Product Overview
  • Recombinant Chimeric antibody to Human CD19. CoR is an anti-CD19 antibody maytansinoid conjugate. CD19 is expressed in the majority of B cell lymphomas
  • Type
  • IgG1 - kappa
  • Species Reactivity
  • Human
  • Expression Host
  • CHO
  • Applications
  • Suitable for use in IF, IP, Neut, FuncS, ELISA, FC, ICC and most other immunological methods.
  • CAS
  • 1269764-99-9
  • Specificity
  • CD19 (B lymphocyte surface antigen B4, Leu-12) [Homo sapiens]
  • Protein Construction
  • gamma1 heavy chain (1-450) [Mus musculus VH (IGHV1-69*02 – (IGHD) – IGHJ4*01) [8.8.13] (1-120) – Homo sapiens IGHG1*01 (CH1 (121-218),hinge (219-233), CH2 (234-343), CH3 (344-448), CHS (449-450)) (121-450)], (223-211') – disulfide withkappa light chain (1'-211') [Mus musculus V-KAPPA (IGKV4-70*01 – IGKJ1*01) [5.3.7] (1'-104') – Homo sapiens IGKC*01 (105'-211')]; dimer (229-229'':232-232'') – bisdisulfide;conjugated, on an average of 3 to 4 lysyl, to maytansinoid DM4
  • Purity
  • >95.0% as determined by analysis by SDS-PAGE.


  • Antigen Description
  • B-lymphocyte antigen CD19 also known as CD19 (Cluster of Differentiation 19), is a protein that in humans is encoded by the CD19 gene. It is found on the surface of B-cells, a type of white blood cell.
  • Function
  • receptor signaling protein activity;
  • Synonyms
  • CD19; CD19 molecule; CD19 antigen; B-lymphocyte antigen CD19; differentiation antigen CD19; T-cell surface antigen Leu-12; B-lymphocyte surface antigen B4; B4; CVID3; MGC12802;

Related Products

Online Inquiry

Verification code
Click image to refresh the verification code.


45-1 Ramsey Road, Shirley, NY 11967, USA
Call us at:
USA: 1-631-381-2994
Europe: 44-207-097-1828
Fax: 1-631-207-8356
Our customer service representatives are available 24 hours a day, 7 days a week. Contact Us